<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674225/" ref="ordinalpos=4705&amp;ncbi_uid=1767274&amp;link_uid=PMC2674225" image-link="/pmc/articles/PMC2674225/figure/fig2/" class="imagepopup">Figure 2..  From: Genomics of Lung Cancer. </a></div><br /><div class="p4l_captionBody">Classification of lung adenocarcinoma reflects progression along a spectrum of invasiveness spanning epithelial atypia, bronchioloalveolar adenocarcinoma (BAC), BAC with foci of microinvasion, and invasive adenocarcinoma. In cells with repression of TGFÎ²-RII (lower panel), signaling through the Smad pathway is abrogated (right). Invasiveness is mediated through noncanonical signaling pathways that require RANTES (left).</div></div>